Cambridge Investment Research Advisors’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,880
Closed -$10K 3202
2022
Q2
$10K Hold
20,880
﹤0.01% 3020
2022
Q1
$48K Hold
20,880
﹤0.01% 3082
2021
Q4
$79K Buy
20,880
+2,475
+13% +$12K ﹤0.01% 3059
2021
Q3
$60K Buy
+18,405
New +$65K ﹤0.01% 3014
2021
Q2
Sell
-138,611
Closed -$1.03M 3190
2021
Q1
$1.03M Buy
138,611
+46,330
+50% +$375K 0.01% 1421
2020
Q4
$663K Buy
92,281
+80,776
+702% +$421K ﹤0.01% 1579
2020
Q3
$38K Sell
11,505
-426
-4% -$1.37K ﹤0.01% 2462
2020
Q2
$41K Buy
+11,931
New +$45.7K ﹤0.01% 2388
2019
Q4
Sell
-12,219
Closed -$39K 2494
2019
Q3
$39K Buy
+12,219
New +$39.4K ﹤0.01% 2296
2018
Q2
Sell
-10,287
Closed -$61K 2273
2018
Q1
$61K Buy
+10,287
New +$71.9K ﹤0.01% 2088

Other funds holding ENDP

Cambridge Investment Research Advisors's ENDP Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Endo International plc (ENDP) in Q3 2022, closing a stake of 20,880 shares — an estimated $10K sold.

Cambridge Investment Research Advisors first reported a position in ENDP in Q1 2018 and held it in 10 quarters. The position peaked at $1.03M in Q1 2021. 12 funds tracked by Wall St. Rank hold ENDP as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Endo International plc position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 20,880 Endo International plc shares in Q3 2022, an estimated $10K.
  • Cambridge Investment Research Advisors first reported a position in Endo International plc in Q1 2018 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's Endo International plc position peaked at $1.03M in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Endo International plc as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.